GeneralConnection.com ➔ Dictionary
Dictionary Search

vanda

Synonyms

Noun

1. orchid

2. orchidaceous plant

Usage
Vanda Pharmaceuticals Appoints Dr. Charles Duncan to its Board of Directors - PR Newswire
[ARS] Vanda Pharmaceuticals Inc. SEC Filing - Stock Titan
Vanda appoints Charles C. Duncan to its board as Class II director - TradingView
It's not just Allbirds - another meme-stock season is on the horizon, Vanda Research says - Reuters
Vanda Pharmaceuticals Adds Independent Director to Strengthen Board - TipRanks
Executive pay, board votes and pipeline in Vanda (NASDAQ: VNDA) 2026 proxy - Stock Titan
Vanda Pharmaceuticals adds Charles Duncan to board By Investing.com - Investing.com South Africa
Vanda initiates study of motion sickness drug Nereus in GLP-1 users - Fierce Pharma
Lara Vanda LACZKO - olympics.com
Vanda Pharmaceuticals Calls on FDA to Withdraw Proposal from FY 2027 Legislative Agenda That Would Extend Drug Review Timelines - PR Newswire
Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations - Yahoo Finance
Charles Duncan joins Vanda Pharmaceuticals (NASDAQ: VNDA) board - Stock Titan
Vanda Pharmaceuticals Announces Initiation of The Thetis Study, a Clinical Trial of NEREUS™ for the Prevention of Vomiting Induced by GLP-1 Receptor Agonists - PR Newswire
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results - PR Newswire
Vanda Pharmaceuticals Announces FDA Acceptance of Biologics License Application Filing for Imsidolimab for the Treatment of Generalized Pustular Psoriasis - PR Newswire
Vanda Announces FDA Grants Landmark Hearing for HETLIOZ® in Jet Lag Disorder, the First Drug Approval Hearing in Over 40 Years - PR Newswire
Vanda Pharmaceuticals Calls for Stronger FDA Action to Accelerate Shift from Animal Testing to Human-Relevant Methods - PR Newswire
Vanda Pharmaceuticals Announces FDA Approval of BYSANTI™ (milsaperidone) for the treatment of Bipolar I Disorder and Schizophrenia - A New Chemical Entity Opening New Horizons in Psychiatric Innovation - PR Newswire
VNDA Vanda Pharmaceuticals beats Q4 2025 EPS forecasts and grows revenue 8.7 percent, yet shares dip 1.17 percent today. - Revenue Breakdown - Cổng thông tin điện tử tỉnh Tây Ninh
Vanda Pharmaceuticals Announces Receipt of FDA Decision Letter on HETLIOZ® Supplemental New Drug Application for Jet Lag Disorder - PR Newswire
Vanda Pharmaceuticals Announces Participation in the 2026 Citizens Life Sciences Conference - PR Newswire
Vanda Pharmaceuticals Announces FDA Approval of NEREUS™ (tradipitant) for the Prevention of Vomiting Induced by Motion: A Historic Scientific Milestone in the Prevention of Motion Sickness - PR Newswire
FDA answers Vanda's yearslong call for public hearing on unsuccessful jet lag approval bid - Fierce Pharma
FDA Accepts Vanda Pharmaceuticals’ BLA for Imsidolimab in Generalized Pustular Psoriasis - Dermatology Times
Vanda Pharmaceuticals Appoints Dr. Charles Duncan to Board of Directors to Drive Growth and Innovation in CNS Therapies 1 - Minichart
Vanda Announces Submission of Biologics License Application to the FDA for Imsidolimab for the Treatment of Generalized Pustular Psoriasis - PR Newswire
US FDA approves Vanda's antipsychotic pill, shares climb - Reuters
Vanda scores FDA approval for oral antipsychotic Bysanti - FirstWord Pharma
FDA approves Vanda Pharmaceuticals’ motion sickness drug Nereus - Pharmaceutical Technology
Vanda Rebounds From Jet Lag Rejection With FDA Nod for Bipolar, Schizophrenia Drug - BioSpace
Where could Vanda Pharmaceuticals (VNDA) stock be by the end of 2026 (+1.54%) 2026-04-18 - Hot Stocks - Cổng thông tin điện tử tỉnh Lào Cai
Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness - PR Newswire
Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026 - Yahoo Finance
Vanda's shares drop after 2nd FDA rejection for Hetlioz in jet lag disorder - Fierce Pharma
Vanda Ends 40-Year Motion Sickness Drug Drought With FDA Approval for Nereus - BioSpace
Vanda's motion sickness drug, Agios' thalassemia treatment make the grade with FDA - Fierce Pharma
Vanda Pharmaceuticals Q4 Earnings Call Highlights - Yahoo Finance
Vanda Pharmaceuticals price target raised to $17 from $14 at B. Riley - Yahoo Finance
Tribute Wall | Vanda Simmons - floralhaven.com
Vanda Pharmaceuticals (VNDA) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Vanda Slides After FDA Again Rejects Hetlioz For Jet Lag - BioSpace
Vanda Pharmaceuticals Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Assessing Vanda Pharmaceuticals (VNDA) Valuation After FDA Approval Of NEREUS For Motion Sickness - Yahoo Finance
FDA again rejects Vanda's Hetlioz for jet lag disorder - FirstWord Pharma
Vanda Ree Kapulani Fields Obituary March 12, 2026 - Gate City Funeral Home
Vanda Pharmaceuticals price target raised to $14 from $11 at B. Riley - Yahoo Finance
Vanda and Exante Data Combine in Strategic Merger - Yahoo Finance
Vanda Pharmaceuticals Reports Positive Results for Tradipitant in Preventing GLP-1 Induced Nausea and Vomiting - PR Newswire
FDA Lifts Partial Clinical Hold on Tradipitant for Motion Sickness - PR Newswire
Vanda Pharmaceuticals: Soaring On Bysanti Approval, But You Shouldn't Feel Dizzy (VNDA) - Seeking Alpha
Vanda Pharma: High Risk, Heavily Discounted - Stock Ahead Of PDUFA This Week (NASDAQ:VNDA) - Seeking Alpha
US FDA approves Vanda Pharmaceuticals' motion sickness drug - Reuters
Vanda (VNDA) Q4 2025 Earnings Call Transcript - The Motley Fool
Vanda Pharmaceuticals Announces Initiation of The Thetis Study, a Clinical Trial of NEREUS™ for the Prevention of Vomiting Induced by GLP-1 Receptor Agonists - ADVFN
FDA lifts partial hold on Vanda’s motion sickness drug following dispute resolution - FirstWord Pharma
FDA Sends Decision Letter to Vanda Pharmaceuticals for NDA of Hetlioz - Pharmaceutical Executive
H.C. Wainwright reiterates Vanda Pharmaceuticals stock rating on GLP-1 trial - Investing.com Canada
Vanda Pharmaceuticals Announces Participation in the J.P. Morgan Healthcare Conference - Yahoo Finance
US retail traders buy silver ETFs faster than tech favorites, Vanda Research says - Reuters
Vanda's 2026 Catalyst Run With Nereus Launch And Bysanti PDUFA In Focus (NASDAQ:VNDA) - Seeking Alpha
Vanda tackles Wegovy-driven vomiting, sparking race to phase 3 - Fierce Biotech
Trending tickers: latest investor updates on Nvidia, Caterpillar, Vanda Pharmaceuticals and Walker Crips - Yahoo Finance UK
Vanda Pharmaceuticals Becomes Presenting Sponsor Of University Of Maryland Basketball - University of Maryland Athletics
Vanda sets Feb. 11 call on Q4 and full-year 2025 results - Stock Titan
Is Vanda Pharmaceuticals (VNDA) Stock priced for growth | Price at $7.07, Down 3.62% - Professional Trade Ideas - Cổng thông tin điện tử tỉnh Tây Ninh
Vanda Pharmaceuticals: SG&A Takes Off, TAM Doesn’t (Rating Downgrade) (VNDA) - Seeking Alpha
Vanda Pharmaceuticals Leads 3 Promising Penny Stocks - Yahoo Finance
FDA clock runs slightly longer on re-review of hold on Vanda's tradipitant - FirstWord Pharma
Vanda (VNDA) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance
Can Vanda Pharmaceuticals (VNDA) Stock Reach New Highs | Price at $7.18, Down 0.55% - Retail Trader Ideas - Cổng thông tin điện tử tỉnh Lào Cai
Vanda Jumps 21% After FDA Approves Motion Sickness Therapy - Yahoo Finance
VNDA Stock Analysis: Vanda Pharmaceuticals Inc. holds $7 level after 0.99 pct daily dip - Cổng thông tin điện tử Tỉnh Sơn La
Vanda Pharmaceuticals (VNDA) Is Up 21.3% After Tradipitant Shows Promise in Reducing Wegovy Side Effects - Yahoo Finance
Vanda ends 40-year hiatus for new motion sickness drugs - pharmaphorum
Vanda Pharmaceuticals Announces Participation in the 2026 Citizens Life Sciences Conference - Financial Times
Is Vanda Pharmaceuticals (VNDA) Stock priced for growth | Price at $7.07, Down 3.62% - Earnings Beat Stocks - Cổng thông tin điện tử tỉnh Lào Cai
Vanda Pharmaceuticals Calls for Stronger FDA Action to Accelerate Shift from Animal Testing to Human-Relevant Methods – Company Announcement - FT.com - Financial Times
Vanda Pharmaceuticals (VNDA): Evaluating Valuation After Successful Tradipitant Trial Results in GLP-1 Therapy Space - Yahoo Finance
Vanda Pharmaceuticals Reports Third Quarter 2025 Financial Results - PR Newswire
Vanda (Nasdaq: VNDA) details FDA hold re-review, labeling talks on tradipitant NDA - Stock Titan
Vanda Pharmaceuticals Signs on as Sponsorship Partner for Georgetown Men’s and Women’s Basketball Games - Georgetown University Athletics
Vanda & Young Global Song Comp Announces 2025 Winners - The Music Network
Assessing Vanda Pharmaceuticals (VNDA) Valuation After Q3 2025 Growth and Updated FDA Milestones - Yahoo Finance
Vanda Pharmaceuticals (VNDA): Revenue Projected to Grow 22.7% Annually, Profitability in Focus Ahead of Earnings - Yahoo Finance
Vanda Pharmaceuticals (VNDA) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Vanda S. (Pfoff) Duncan Obituary October 5, 2024 - Mason Funeral Homes | Metamora, IL
MM 11.7: Maryland basketball announces Vanda Pharmaceuticals as presenting sponsor - Testudo Times
Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness - Finansavisen
UGM Students Plant Vanda Tricolor Orchids on Slopes of Mount Merapi - Universitas Gadjah Mada
Vanda Pharmaceuticals Reports Positive Results for Tradipitant in Preventing GLP-1 Induced Nausea and Vomiting - Finansavisen
Acquisition of Exante Data by Vanda, an FPE portfolio company - BDO UK
Vanda Pharmaceuticals Becomes Presenting Sponsor of Men’s Basketball Season and Smith Center Celebration - George Washington University Athletics
Vanda Pharmaceuticals Announces Collaborative Framework for Resolution of Disputes with the U.S. Food and Drug Administration - PR Newswire
New York Islanders Name Vanda Pharmaceuticals as Team’s Jersey Patch Partner in Milestone NHL Agreement - NHL.com
In a Major Win for Vanda, a Federal Appeals Court Overturns FDA's Order Denying Approval of Hetlioz for the Treatment of Jet Lag Disorder - PR Newswire
Vanda Pharmaceuticals Announces FDA Granted Orphan Drug Designation for VGT-1849B, a Novel and Selective Candidate for the Treatment of Polycythemia Vera - PR Newswire
Vanda Pharmaceuticals Reports Second Quarter 2025 Financial Results - PR Newswire
After court win, Vanda reaches accord with FDA on Hetlioz, tradipitant reviews - FirstWord Pharma
Mia Hewitt’s shock wedding! - Now To Love
Monumental Sports & Entertainment Taps D.C.'s Own Vanda Pharmaceuticals as Founding Partner to Help Drive the Creation of Brand-New Downtown Arena - PR Newswire
Foreign Language Equivalents
Foreign Language Equivalents of 'vanda'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
vvanda,   anda,   vamda,   vabda,   banda,   vadna,   vands,   vansa,   vada,   vand,   vandaa,   vanfa,   vaanda,   vsnda,   vandda,   vnada,   avnda,   vnda,   vanad,   canda,   vannda,   vana
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z